Celgene

Celgene Corporation is a global, integrated biopharmaceutical company primarily engaged in the discovery, development, and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Investigational compounds are being studied for patients with incurable hematologic malignancies and solid tumors, including multiple myeloma (MM), myelodysplastic syndromes (MDS), chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma (NHL), pancreatic cancer, non-small cell lung cancer, and melanoma.